tiprankstipranks
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Technical Analysis

72 Followers

Technical Sentiment

Overall Consensus
Sell
8Bullish
2Neutral
12Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
NewAmsterdam Pharma Company’s (NAMS) Moving Averages Convergence Divergence (MACD) indicator is -0.09, suggesting NewAmsterdam Pharma Company is a Buy.
NewAmsterdam Pharma Company’s (NAMS) 20-Day exponential moving average is 19.52, while NewAmsterdam Pharma Company’s (NAMS) share price is $18.9, making it a Sell.
NewAmsterdam Pharma Company’s (NAMS) 50-Day exponential moving average is 19.69, while NewAmsterdam Pharma Company’s (NAMS) share price is $18.9, making it a Sell.

NewAmsterdam Pharma Company (NAMS) Pivot Points

Jul 22, 2024, 06:55 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
16.09
17.12
17.94
18.97
19.79
20.82
21.64
Fibonacci
17.12
17.83
18.26
18.97
19.68
20.11
20.82
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NewAmsterdam Pharma Company (NAMS) Moving Averages

Jul 22, 2024, 06:55 AM
Period
Simple
Exponential
MA5
19.07Sell
19.12Sell
MA10
19.71Sell
19.41Sell
MA20
19.69Sell
19.52Sell
MA50
19.56Sell
19.69Sell
MA100
20.58Sell
19.36Sell
MA200
16.74Buy
16.47Buy
NewAmsterdam Pharma Company’s (NAMS) 10-Day exponential moving average is 19.41, while NewAmsterdam Pharma Company’s (NAMS) share price is $18.9, making it a Sell.
NewAmsterdam Pharma Company’s (NAMS) 100-Day exponential moving average is 19.36, while NewAmsterdam Pharma Company’s (NAMS) share price is $18.9, making it a Sell.
NewAmsterdam Pharma Company’s (NAMS) stock price is $18.9 and NewAmsterdam Pharma Company’s (NAMS) 50-day simple moving average is 19.56, creating a Sell signal.
NewAmsterdam Pharma Company’s (NAMS) stock price is $18.9 and NewAmsterdam Pharma Company’s (NAMS) 100-day simple moving average is 20.58, creating a Sell signal.
NewAmsterdam Pharma Company’s (NAMS) stock price is $18.9 and NewAmsterdam Pharma Company’s (NAMS) 200-day simple moving average is 16.74, creating a Buy signal.

NewAmsterdam Pharma Company (NAMS) Technical Indicators

Jul 22, 2024, 06:55 AM
Name
Value
Implied Action
RSI (14)
43.36
Neutral
STOCH (9,6)
16.47
Buy
STOCHRSI (14)
16.47
Buy
MACD (12,26)
-0.09
Buy
ADX (14)
15.44
Buy
Williams %R
-77.48
Buy
CCI (14)
-106.95
Buy
ATR (14)
1.04
-
Ultimate Oscillator
34.81
Neutral
ROC
-1.61
Sell
NewAmsterdam Pharma Company’s (NAMS) Relative Strength Index (RSI) is 43.36, creating a Neutral signal.
NewAmsterdam Pharma Company’s (NAMS) Trend Strength Indicator (ADX) is 15.44, creating a Buy signal.
NewAmsterdam Pharma Company’s (NAMS) Commodity Channel Index (CCI) is -106.95, creating a Buy signal.
NewAmsterdam Pharma Company’s (NAMS) Price Rate of Change (ROC) is -1.61, creating a Sell signal.

FAQ

Is NAMS a Buy, Hold, or Sell?
Based on NAMS’s technical indicators, NAMS is a Sell.
    What is NAMS’s RSI (14)?
    NAMS’s RSI (14) is 43.36, which suggests NAMS is a Neutral.
      What is NAMS’s MACD?
      NAMS’s MACD is -0.09, which suggests NAMS is a Buy.
        What is NAMS’s 5-day moving average?
        NAMS’s 5-day moving average is 19.07, which suggests NAMS is a Sell.
          What is NAMS’s 20-day moving average?
          NAMS 20-day moving average is 19.69, which suggests NAMS is a Sell.
            What is NAMS’s 50-day moving average?
            NAMS’s 50-day moving average is 19.56, which suggests NAMS is a Sell.
              What is NAMS’s 200-day moving average?
              NAMS’s 200-day moving average is 16.74, which suggests NAMS is a Buy.
                What is NAMS’s Williams % R (14)?
                NAMS’s Williams % R (14) is -77.48, which suggests NAMS is a Buy.
                  What is NAMS’s CCI (14)?
                  NAMS’s CCI (14) is -106.95, which suggests NAMS is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis